Deep Track Capital »

Veradermics shares owned by Deep Track Capital

Quarter-by-quarter ownership of Veradermics shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Veradermics

Tip: Access up to 7 years of quarterly data

All positions including Veradermics held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veradermics by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $32M 500k 63.15

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Immunovant (IMVT)
Tarsus Pharmaceuticals (TARS)
Vaxcyte (PCVX)
Structure Therapeutics Sponsored Ads (GPCR)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Ocular Therapeutix (OCUL)
Vera Therapeutics Cl A (VERA)
Alumis (ALMS)
Ionis Pharmaceuticals (IONS)
Nuvalent Inc-a (NUVL)
Alkermes SHS (ALKS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Deep Track Capital

Top funds holding Veradermics

Suvretta Capital Management
Citadel Advisors
Viking Global Investors
Standard Life Aberdeen
Infinitum Asset Management
Vanguard Capital Management
Balyasny Asset Management
Paradigm Biocapital Advisors
Ameriprise Financial
Woodline Partners
Deep Track Capital
UBS Group
Vivo Capital
Stifel Financial
BlackRock

View all funds holding Veradermics